Page last updated: 2024-10-15
2',3'-cyclic gmp
Description
2',3'-cyclic GMP: was GUANOSINE CYCLIC 2',3'-MONOPHOSPHATE see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93; use CYCLIC GMP to search 1980-93 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
2',3'-cyclic GMP : A 2',3'-cyclic purine nucleotide in which guanosine is used as the parent nucleoside. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 135398728 |
CHEBI ID | 28181 |
SCHEMBL ID | 4063650 |
MeSH ID | M0209617 |
Synonyms (32)
Synonym |
---|
guanosine cyclic-2',3'-monophosphate |
CHEBI:28181 |
cyclic guanosine 2',3'-monophosphate |
o(2'),o(3')-hydroxyphosphoryl-guanosine |
guanosine cyclic 2',3'-(hydrogen phosphate) |
guanosine 2',3'-cyclic phosphate |
2',3'-cyclic gmp |
C06194 , |
guanosine 2',3'-cyclic monophosphate |
34DF8A42-40BB-441B-A058-8E0008232C94 |
guanosine-2',3'-cyclic-monophosphate |
634-02-6 |
2-amino-9-[(3ar,4r,6r,6ar)-2-hydroxy-6-(hydroxymethyl)-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]-1,9-dihydro-6h-purin-6-one |
9-[(3ar,4r,6r,6ar)-2-hydroxy-6-(hydroxymethyl)-2-oxo-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]-2-amino-3h-purin-6-one |
15718-49-7 |
vgu8zu3am5 , |
unii-vgu8zu3am5 |
einecs 211-203-0 |
SCHEMBL4063650 |
2',3'-cgmp |
9-[(3ar,4r,6r,6ar)-2-hydroxy-6-(hydroxymethyl)-2-oxo-tetrahydro-2h-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-4-yl]-2-amino-6,9-dihydro-3h-purin-6-one |
cyclic 2',3'-(hydrogen phosphate)-guanosine |
2',3' cgmp |
9k9 , |
2-amino-9-[(2s,3ar,4r,6r,6ar)-2-hydroxy-6-(hydroxymethyl)-2-oxotetrahydro-2h-2lambda~5~-furo[3,4-d][1,3,2]dioxaphosphol-4-yl]-3,9-dihydro-6h-purin-6-one |
23G , |
Q27103546 |
DTXSID80979568 |
2-hydroxy-4-(6-hydroxy-2-imino-2,3-dihydro-9h-purin-9-yl)-6-(hydroxymethyl)tetrahydro-2h-2lambda~5~-furo[3,4-d][1,3,2]dioxaphosphol-2-one |
9-((3ar,4r,6r,6ar)-2-hydroxy-6-(hydroxymethyl)-2-oxo-3a,4,6,6a-tetrahydrofuro(3,4-d)(1,3,2)dioxaphosphol-4-yl)-2-amino-1h-purin-6-one |
guanosine cyclic 2',3'-phosphate |
2',3'-cyclic guanylic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Roles (1)
Role | Description |
---|---|
Escherichia coli metabolite | Any bacterial metabolite produced during a metabolic reaction in Escherichia coli. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
---|---|
2',3'-cyclic purine nucleotide | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |